on May 11, 2006
Published online before print May 11, 2006, doi: 10.1161/01.ATV.0000226543.77214.e4
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 18, 2006
Accepted on May 1, 2006
Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction
Dov Shiffman *;
From Celera Inc. (D.S., C.M.R., J.Z.L., M.M.L., L.A.B., J.I.B., B.A.Y., J.J.C., J.J.D.), Alameda, Calif; Brigham Young University (C.F.S.), University Station, Provo, Utah; Cardiovascular Research Institute (C.R.P., M.J.M., J.P.K.), University of California San Francisco; Case Western Reserve University (E.J.T.), Department of Genetics, Cleveland, Ohio; and the Cleveland Clinic Foundation (S.G.E.), Department of Cardiovascular Medicine, Ohio.
* To whom correspondence should be addressed. E-mail: dov.shiffman{at}celeradiagnostics.com.
Objectives--Identify gene variants associated with early-onset myocardial infarction (MI).
Methods and Results--We tested 11 647 single-nucleotide polymorphisms (SNPs) for association with early-onset MI in a case-control study (study 1 200 cases, 262 controls). To reduce the number of false positives among the 666 SNPs that were nominally associated with early-onset MI (P<0.05) in study 1, we tested these SNPs in study 2 (434 cases, 504 controls). We found that 8 of the 666 SNPs were associated with early-onset MI in study 2 (P<0.05) and had the same risk alleles as in study 1. These 8 SNPs were then tested for association with early-onset MI in study 3 (187 cases, 434 controls). We found that a VAMP8 variant (P=0.025; odds ratio [OR], 1.75; CI, 1.17 to 2.62) and an HNRPUL1 variant (P=0.0043; OR, 1.92; CI, 1.28 to 2.86) were associated with early-onset MI (nominal P<0.05; false discovery rate <10%) and had the same risk alleles in all 3 studies.
Conclusions--Variants in 2 genes were associated with early-onset MI: VAMP8, which is involved in platelet degranulation, and HNRPUL1, which encodes a ribonuclear protein. The identification of these variants could improve understanding of disease mechanisms and suggest novel drug targets.
Key words: myocardial infarction • genetics • polymorphism • single nucleotide • risk factors • VAMP8
This article has been cited by other articles:
 |
|
 |
|
  I. D. Bezemer, A. R. Arellano, C. H. Tong, C. M. Rowland, H. A. Ireland, K. A. Bauer, J. Catanese, P. H. Reitsma, C. J.M. Doggen, J. J. Devlin, et al. F9 Malmo, factor IX and deep vein thrombosis Haematologica, May 1, 2009; 94(5): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wang and T. S. Furey Analysis of Complex Disease Association and Linkage Studies Using the University of California Santa Cruz Genome Browser Circ Cardiovasc Genet, April 1, 2009; 2(2): 199 - 204. [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Luke, E. S. O'Meara, C. M. Rowland, D. Shiffman, L. A. Bare, A. R. Arellano, W.T. Longstreth Jr, T. Lumley, K. Rice, R. P. Tracy, et al. Gene Variants Associated With Ischemic Stroke: The Cardiovascular Health Study Stroke, February 1, 2009; 40(2): 363 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Chan, F. Andreotti, and R. C. Becker Hypercoagulable States in Cardiovascular Disease Circulation, November 25, 2008; 118(22): 2286 - 2297. [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. van der Net, D. M. Oosterveer, J. Versmissen, J. C. Defesche, M. Yazdanpanah, B. E. Aouizerat, E. W. Steyerberg, M. J. Malloy, C. R. Pullinger, J. J.P. Kastelein, et al. Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia Eur. Heart J., September 2, 2008; 29(18): 2195 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. D. Bezemer, L. A. Bare, C. J. M. Doggen, A. R. Arellano, C. Tong, C. M. Rowland, J. Catanese, B. A. Young, P. H. Reitsma, J. J. Devlin, et al. Gene Variants Associated With Deep Vein Thrombosis JAMA, March 19, 2008; 299(11): 1306 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Shiffman, E. S. O'Meara, L. A. Bare, C. M. Rowland, J. Z. Louie, A. R. Arellano, T. Lumley, K. Rice, O. Iakoubova, M. M. Luke, et al. Association of Gene Variants With Incident Myocardial Infarction in the Cardiovascular Health Study Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Damani and E. J. Topol Future Use of Genomics in Coronary Artery Disease J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1933 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Luke, J. P. Kane, D. M. Liu, C. M. Rowland, D. Shiffman, J. Cassano, J. J. Catanese, C. R. Pullinger, D. U. Leong, A. R. Arellano, et al. A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 2030 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K Luo, B. K Jefferson, M. J Garcia, G. S Ginsburg, and E. J Topol Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease J. Med. Genet., March 1, 2007; 44(3): 161 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Topol, J. Smith, E. F. Plow, and Q. K. Wang Genetic susceptibility to myocardial infarction and coronary artery disease Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R117 - R123. [Abstract] [Full Text] [PDF]
|
|